Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets via integrated bioinformatics analysis and experimental validation
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignancy. Epidemiologically, the incidence of DLBCL is higher in men, and the female sex is a favorable prognostic factor, which can be explained by estrogen. This study aimed to explore the potential targets of the estrogen receptor...
Main Authors: | Bo Chen, Tianjiao Mao, Xiuni Qin, Wenqi Zhang, Nobumoto Watanabe, Jiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1029998/full |
Similar Items
-
An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy
by: Marta Rodríguez, et al.
Published: (2022-08-01) -
Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients
by: Anna Nydegger, et al.
Published: (2021-12-01) -
Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model
by: Jinrong Zhao, et al.
Published: (2022-08-01) -
The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms
by: Somayeh Yazdanparast, et al.
Published: (2022-06-01) -
Immunogenic Cell Death (ICD)-Related Gene Signature Could Predict the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
by: Liqin Ping, et al.
Published: (2022-11-01)